Abstract
A calcium-activated neutral proteinase was purified from myelin of bovine brain white matter. Myelin purified in the presence of EDTA (2 mM) was homogenized in 50 mM Trisacetate buffer at pH 7.5, containing 4 mM EDTA, 1 mM NaN3, 5 mM β-mercaptoethanol and 0.1% Triton X-100 for two hours. After centrifugation at 87,000g for 1 hour, the supernatant was subjected to purification through successive column chromatography as follows: i) DEAE-cellulose, ii) Ultrogel (AC-34) filtration, iii) Phenyl-Sepharose, iv) a second DEAE-cellulose. The enzyme activity was assayed using azocasein as substrate. The myelin enzyme was purified 2072-fold and SDS-PAGE analysis of the purified enzyme revealed a major subunit of 72–76 K. The enzyme was inhibited by iodoacetate (1 mM), leupeptin (1 mM), E-64C (1.6 mM), EGTA (1 mM), antipain (2 mM) and endogenous inhibitor calpastatin (2 μg). It required 0.8 mM Ca2+ for half-maximal activation and 5 mM Ca2+ for optimal activation. Mg2+ (5 mM) was ineffective while Zn2+ and Hg2+ were inhibitory. The pH optimum was ranged from 7.5–8.5. Treatment of myelin with Triton X-100 increased the enzyme activity by 10-fold suggesting it is membrane bound whereas the purufied enzyme was not activated by Triton X-100 treatment. The presence of CANP in myelin may mediate the turnover of myelin proteins and myelin breakdown in degenerative brain diseases.
Similar content being viewed by others
References
Guroff, G. 1964. A neutral calcium-activated proteinase from the soluble fraction of rat brain. J. Biol. Chem. 239:149–155.
Dayton, W. R., Goll, D. E., Zeece, M. G., Robson, R. M., and Reville, W. J. 1976. A calcium-activated protease posibly involved in myofibrillar protein turnover. Purification from porcine muscle. Biochemistry 15:2150–2158.
Azanza, J. L., Raymond, J., Robin, J. M., Coffin, P., and Ducastaing, A. 1979. Purification and some physicochemical and enzymic properties of a calcium ion-activated neutral protease from rabbit skeletal muscle. Biochem. J. 183:339–347.
Murachi, T. 1984. Calcium-dependent proteinases and specific inhibitors calpain and calpastatin. Biochem. Soc. Symp. 49:149–167.
Banik, N. L., Hogan, E. L., Jerkins, M. G., McDonald, J. K., McAlhaney, W. W. and Sostek, M. B. 1983. Purification of a calcium-activated neutral proteinase from bovine brain. Neurochem. Res. 8:1389–1405.
Vitto, A., and Nixon, R. A. 1986. Calcium-activated neutral proteinase of human brain: subunit structure and enzymatic properties of multiple molecular forms. J. Neurochem. 47:1039–1051.
Mellgren, R. L. 1980. Canine cardiac calcium dependent proteases: Resolution of two forms with different requirements for calcium. FEBS. Lett. 109:129–133.
Kubota, S-i., Suzuki, K. and Imahori, K. 1981. A new method for the preparation of a calcium activated neutral protease highly sensitive to calcium ions. Biochem. Biophys. Res. Commun. 100:1189–1194.
Croall, D. E., and DeMartino, G. N. 1983. Purification and characterization of calcium dependent proteases from rat heart. J. Biol. Chem. 258:5660–5665.
Ishiura, S. 1981. Calcium dependent proteolysis in living cells. Life Sci. 29:1079–1087.
Hogan, E. L., and Banik, N. L. 1985. Biochemistry of the spinal cord Pages 285–337, in Lajtha, (ed.) Handbook of Neurochemistry, Vol. 10, Plenum Publishing Corporation.
Schlaepfer, W. W. 1977. Vascular disruption of myelin stimulated by exposure of nerve to calcium ionophore. Nature 265:734–736.
Baudry, M., Bundman, M. C., Smith, E. K., and Lynch, G. S. 1981. Micromolar calcium stimulates proteolysis and glutamate binding in rat brain synaptic membranes. Science 212:937.
Burgoyne, R. B., and Cumming, R. 1983. Calcium-dependent proteolysis of microtubule-associated proteins in brain and synaptosomal cytosol. Biochem. Soc. Trans. 11:158–159.
Malik, M. N., Fenko, M. D., and Wisniewski, H. M. 1984. Purification and partial characterization of two forms of Ca2+-activated neutral protease from calf brain synaptosomes and spinal cord. Neurochem. Res. 9:233–240.
Sato, S., Quarles, R. H., and Brady, R. O. 1982. Susceptibility of myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J. Neurochem. 39:97–105.
Singh, I., and Singh, A. 1983. Degradation of myelin proteins by brain endogenous neutral protease. Neurosci. Lett. 39:77–82.
Banik, N. L., McAlhaney, W. W., and Hogan, E. L. 1985. Calcium simulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS. J. Neurochem. 45:581–588.
DeRosbo, N. K., Carnegie, P. R., and Bernard, C. C. A. 1986. Quantitative electroimmunoblotting study of the calcium-activated neutral proteinase in human myelin. J. Neurochem. 47:1007–1012.
Banik, N. L., Chakrabarti, A. K., and Hogan, E. L. 1987. Regional and subcellular distribution of calcium-activated neutral proteinase in bovine CNS. J. Neurochem 48 (Suppl.): S135.
Berlet, H. H. 1987. Calcium-dependent neutral protease activity of myelin from bovine spinal cord: evidence for soluble cleavage products of myelin proteins. Neuroscience Letters 73:266–270.
Gopalakrishna, R., and Head, J. F. 1985. Rapid purification of calcium-activated protease by calcium-dependent hydrophobic-interaction chromatography. FEBS Lett. 186:246–250.
Otsuka, Y., and Tanaka, H. 1983. Purification of a new calcium activated protease (low calcium requiring form) and comparison to high calcium requiring Form. Biochem. Biophys. Res. Commun. 111(2):700–709.
Chakrabarti, A. K., and Banik, N. L. 1987. Purification of calcium-activated neutral proteinase from purified myelin of bovine brain. J. Neurochem 48 (Suppl.): S149.
Norton, W. T., and Poduslo, S. E. 1973. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:749–757.
Parkes, C., Kembhabi, A. A., and Barrett, A. J. 1985. Calpain inhibition by peptide epoxides. Biochem. J. 230:509–516.
Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Bichem. 72:248–254.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
Klymosky, M. W., and Dutcher, S. K. 1984. Nitrocellulose immobilized antigen presentation used to generate monoclonal antibodies against chlamydomonas reinhardtii basal bodies. J. Cell Biol: 99:187.
Towbin, H., Staehelin, T., and Gordon, J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc. Natl. Acad. Sci. U.S.A. 76:4350–4354.
Greenfield, S., Weise, M. J., Gantt, G., Hogan, E. L., and Brostoff, S. W. 1982. Basic proteins of rodent peripheral nerve myelin. Immunochemical identification of the 21.5 K, 17 K, 14 K and P2 proteins. J. Neurochem. 39:1278–1282.
McAlhaney, W. W., Gaan, J. L., Banik, N. L., and Hogan, E. L. 1985. Isolation of an endogenous inhibitor of Ca2+-activated neutral proteinase from CNS. J. Neurochem. 44:Suppl., 165.
Zimmerman, U. J. P., and Schlaepfer, W. W. 1982. Characterization of a brain calcium-activated protease that degrades neurofilament proteins. Biochemistry 21:3977–3983.
Malik, M. N., Fenko, M. D., Iqbal, K., and Wisniewski, H. M. 1983. Purification and characterization of two forms of Ca2+-activated neutral protease from calf brain. J. Biol. Chem. 258:8955–8962.
Sato, S., and Miyatake, T. 1982. Degradation of myelin basic protein by calcium-activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue. Biomed. Res. 3:461–464.
Dayton, W. R., Schollmeyer, J. V., Lepley, R. A., and Cortes, L. R. 1981. A calcium-activated protease possibly involved in myofibrillar protein turnover. Biochim. Biophys. Acta 659:48–61.
Nelson, W. J., and Traub, P. 1982. Purification and further characterization of the Ca2+-activated proteinase specific for the intermediate filament proteins vimentin and desmin. J. Biol. Chem. 257:5544–5553.
Nishiura, I., Handa, H., and Murachi, T. 1979. The role of intracellular proteases in brain tumor. Neurol. Med. Chir. (Tokyo) 19:1–7.
Murachi, T., Tanaka, K., Hatanaka, M., and Murakami, T. 1981. Intracellular Ca2+-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin). Adv. Enz. Regulat. 19:407–424.
DeMartino, G. N., Huff, C. A., and Croall, D. E. 1986. Autoproteolysis of the small subunit of calcium dependent protease II activates and regulates protease activity. Fed. Proceed. 45(6):1917.
Zimmerman, U. J. P. and Schlaepfer, W. W. 1984. Multiple forms of Ca-activated protease from rat brain and muscle. J. Biol. Chem. 2595:3210–3218.
Banik, N. L., Goll, D. E., Gantt, G. and Hogan, E. L. 1986. Cross reactivity of muscle-calcium-activated neutral proteinase (CANP) antisera with CANP of CNS in different species. Trans. Soc. Neurosci. 12, p. 452.
Banik, N. L., Happel, R., Sostek, M., Chiu, F. C., and Hogan, E. L., 1987 Calcium-mediated degradation of CNS proteins: Topographic and species variation. Metab. Brain Dis. 2:117–126.
Stracher, A., McGowan, E. B., and Shafique, S. A. 1978. Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors. Science 200:50–51.
Libby, P., and Goldberg, A. L. 1978. Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles. Science 199:534–536.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chakrabarti, A.K., Banik, N.L. Purification of calcium-activated neutral proteinase (CANP) from purified myelin of bovine brain white matter. Neurochem Res 13, 127–134 (1988). https://doi.org/10.1007/BF00973324
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00973324